| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Calycosin | Bone Cancer | 1 | PM | 34311656 | 📋 | Anti-neoplastic characteristics and potential targets of calycosin against bisphenol A-related osteosarcoma: bioinformatics analysis |
| Calycosin | Breast Cancer | 4 | PM | 37393829 | 📋 | Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway |
| Calycosin | Breast Cancer | 3 | PM | 36647722 | 📋 | Inhibitory effect of calycosin on breast cancer cell progression through downregulating lncRNA HOTAIR and downstream targets: HuR and IGF2BP1 |
| Calycosin | Breast Cancer | 2 | PM | 34096887 | 📋 | Calycosin inhibits breast cancer cell migration and invasion by suppressing EMT via BATF/TGF-β1 |
| Calycosin | Breast Cancer | 1 | PM | 33647882 | 📋 | Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα |
| Calycosin | Breast Cancer | 6 | PM | 24355881 | 📋 | Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin |
| Calycosin | Breast Cancer | 5 | PM | 23609007 | 📋 | Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7 |
| Calycosin | Cancer | 2 | PM | 38701310 | 📋 | Exploring the multi-targeting phytoestrogen potential of Calycosin for cancer treatment: A review |
| Calycosin | Cancer | 1 | PM | 38230908 | 📋 | Unveiling the potential anti-cancer activity of calycosin against multivarious cancers with molecular insights: A promising frontier in cancer research |
| Calycosin | Colon Cancer | 1 | PM | 36755950 | 📋 | Uncovering the effects and molecular mechanism of Astragalus membranaceus (Fisch.) Bunge and its bioactive ingredients formononetin and calycosin against colon cancer: An integrated approach based on network pharmacology analysis coupled with experimental validation and molecular docking |
| Calycosin | Colorectal Cancer | 1 | PM | 35842774 | 📋 | Calycosin suppresses colorectal cancer progression by targeting ERβ, upregulating PTEN, and inhibiting PI3K/Akt signal pathway |
| Calycosin | Colorectal Cancer | 2 | PM | 27393650 | 📋 | Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways |
| Calycosin | Gastric Cancer | 1 | PM | 33883905 | 📋 | Calycosin Induces Gastric Cancer Cell Apoptosis via the ROS-Mediated MAPK/STAT3/NF-κB Pathway |
| Calycosin | Glioma | 3 | PM | 38461458 | 📋 | Calycosin (CA) inhibits proliferation, migration and invasion by suppression of CXCL10 signaling pathway in glioma |
| Calycosin | Glioma | 2 | PM | 36076540 | 📋 | The mechanism of formononetin/calycosin compound optimizing the effects of temozolomide on C6 malignant glioma based on metabolomics and network pharmacology |
| Calycosin | Glioma | 1 | PM | 31005632 | 📋 | In vitro and in vivo Study on Glioma Treatment Enhancement by Combining Temozolomide with Calycosin and Formononetin |
| Calycosin | Liver Cancer | 2 | PM | 34186122 | 📋 | Enhancement of interferon gamma stability as an anticancer therapeutic protein against hepatocellular carcinoma upon interaction with calycosin |
| Calycosin | Liver Cancer | 1 | PM | 33188878 | 📋 | Calycosin induces mitochondrial-dependent apoptosis and cell cycle arrest, and inhibits cell migration through a ROS-mediated signaling pathway in HepG2 hepatocellular carcinoma cells |
| Calycosin | Lung Cancer | 1 | PM | 37635478 | 📋 | Calycosin inhibits gemcitabine-resistant lung cancer cells proliferation through modulation of the LDOC1/GNL3L/NFκB |
| Calycosin | Pancreatic Cancer | 1 | PM | 35968328 | 📋 | MUC1 is responsible for the pro-metastatic potential of calycosin in pancreatic ductal adenocarcinoma |
| Calycosin | Thyroid Cancer | 1 | PM | 36588732 | 📋 | Calycosin induces autophagy and apoptosis via Sestrin2/AMPK/mTOR in human papillary thyroid cancer cells |
